{"id":45402,"date":"2024-01-24T13:31:56","date_gmt":"2024-01-24T13:31:56","guid":{"rendered":"https:\/?p=45402"},"modified":"2024-01-24T13:31:56","modified_gmt":"2024-01-24T13:31:56","slug":"elevance-healths-stock-soars-on-impressive-q4-earnings","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/","title":{"rendered":"Elevance Health&#8217;s Stock Soars on Impressive Q4 Earnings"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Elevance Health Inc. (<\/span><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/ELV\"><span style=\"font-weight: 400;\">ELV: NYE<\/span><\/a><span style=\"font-weight: 400;\">) saw its stock surge on Wednesday after the company reported strong financial results for the fourth quarter of 2023, exceeding analyst expectations. <\/span><span style=\"font-weight: 400;\">With the 8% pre-market stock surge, the positive investor sentiment towards Elevance Health&#8217;s robust Q4 results is evident.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/ELV\" target=\"_blank\" rel=\"noopener\">ELV Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ELV\" data-theme=\"wt_bg_trans\" data-uid=\"69699712365b10fbb87c8c65b10fbb87c8e\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h2><strong>Stock Target Advisor\u2019s Analysis on Elevance Health:<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.stocktargetadvisor.com\/\">Stock Target Advisor<\/a> rates Elevance Health Inc. <\/span><span style=\"font-weight: 400;\">as a &#8220;Strong Buy&#8221; in light of its commendable performance and promising predictions. The average analyst target price over the next 12 months for Elevance Health is projected at a lucrative USD 560.83.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The recommendation is underpinned by a number of positive indicators such as low debt levels, underpriced cash flow, subdued volatility, and superior returns. It&#8217;s worth noting, however, that negative signals from a trailing 12 months return analysis and certain volatility metrics should be considered.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The &#8220;Emerging Markets Equity&#8221; sector in the NYE, where Elevance Health resides, enjoys a strong average analyst rating and a Very Bullish assessment by us at Stock Target Advisor.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Key Highlights from Q4 Earnings Report:<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Here are the key insights from the Q4 report of Elevance Health:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><strong>Earnings per share (EPS):<\/strong> $2.50, compared to analyst estimates of $2.35, representing a 6.4% beat.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><strong>Revenue:<\/strong> $3.2 billion, exceeding analyst expectations of $3.15 billion, signifying a 7.6% year-over-year increase.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><strong>Medical loss ratio (MLR):<\/strong> 82.5%, slightly better than the prior quarter and lower than analysts&#8217; anticipated 83%.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><strong>Membership growth:<\/strong> The company added 83,000 new members during the quarter, exceeding its own guidance of 75,000.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><strong>Conclusion:<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">The robust Q4 2023 results, coupled with encouraging guidance, support Elevance Health Inc. (<a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/ELV\">ELV: NYE<\/a>) as a promising investment option. Positive stock assessment and the bullish market sentiment lend further credibility. As always, investors are recommended to consult with their financial advisors before making investment decisions.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Elevance Health Inc. (ELV: NYE) saw its stock surge on Wednesday after the company reported strong financial results for the fourth quarter of 2023, exceeding&#8230;<\/p>\n","protected":false},"author":17,"featured_media":40150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-45402","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Elevance Health&#039;s Stock Soars on Impressive Q4 Earnings<\/title>\n<meta name=\"description\" content=\"Discover how Elevance Health&#039;s impressive Q4 earnings and positive investor sentiment make it a promising investment option.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elevance Health&#039;s Stock Soars on Impressive Q4 Earnings\" \/>\n<meta property=\"og:description\" content=\"Discover how Elevance Health&#039;s impressive Q4 earnings and positive investor sentiment make it a promising investment option.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-24T13:31:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-2023-09-18T175935.532.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"Elevance Health&#8217;s Stock Soars on Impressive Q4 Earnings\",\"datePublished\":\"2024-01-24T13:31:56+00:00\",\"dateModified\":\"2024-01-24T13:31:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\"},\"wordCount\":294,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\",\"name\":\"Elevance Health's Stock Soars on Impressive Q4 Earnings\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-01-24T13:31:56+00:00\",\"dateModified\":\"2024-01-24T13:31:56+00:00\",\"description\":\"Discover how Elevance Health's impressive Q4 earnings and positive investor sentiment make it a promising investment option.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elevance Health&#8217;s Stock Soars on Impressive Q4 Earnings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Elevance Health's Stock Soars on Impressive Q4 Earnings","description":"Discover how Elevance Health's impressive Q4 earnings and positive investor sentiment make it a promising investment option.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/","og_locale":"en_US","og_type":"article","og_title":"Elevance Health's Stock Soars on Impressive Q4 Earnings","og_description":"Discover how Elevance Health's impressive Q4 earnings and positive investor sentiment make it a promising investment option.","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-01-24T13:31:56+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-2023-09-18T175935.532.png","type":"image\/png"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"Elevance Health&#8217;s Stock Soars on Impressive Q4 Earnings","datePublished":"2024-01-24T13:31:56+00:00","dateModified":"2024-01-24T13:31:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/"},"wordCount":294,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/","name":"Elevance Health's Stock Soars on Impressive Q4 Earnings","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-01-24T13:31:56+00:00","dateModified":"2024-01-24T13:31:56+00:00","description":"Discover how Elevance Health's impressive Q4 earnings and positive investor sentiment make it a promising investment option.","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/elevance-healths-stock-soars-on-impressive-q4-earnings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Elevance Health&#8217;s Stock Soars on Impressive Q4 Earnings"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=45402"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45402\/revisions"}],"predecessor-version":[{"id":45404,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45402\/revisions\/45404"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/40150"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=45402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=45402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=45402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}